Media.Player

Anticancer vaccine and diagnostic methods and reagents

Detailed Technology Description

None

*Abstract

The invention provides a method of priming T cells against tumor antigens comprising by obtaining naive CD4 or CD8 T cells from at least one healthy individual, obtaining at least one protein or peptide from at least one cancerous cell; obtaining antigen presenting cells (APCs), culturing the APCs with the at least one protein or peptide, and adding the T cells to the culture of the APCs. The primed T cells can then be employed to identify the antigens or therapeutically as prophylaxis or treatment for cancers. The invention also provides cyclin molecules, and fragments derived from cyclin molecules, as tumor antigens. The invention provides a method for diagnosing a malignant or pre-malignant condition within a patient. The invention also provides a method for vaccinating a patient against malignancies comprising introducing a protein or peptide consisting essentially of all or an immunogenic fragment of a cyclin protein into the patient. Patent allowed, PCT patent application filed

*Principal Investigator

Name: Olivera Finn, Professor

Department: Med-Immunology

Name: Donald Hunt, Professor

Department:

Name: Henry Kao

Department:

Name: Jarrod Marto, Research Faculty

Department:

Country/Region

USA